pd 98059 has been researched along with 6-methyl-2-(phenylethynyl)pyridine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Auld, DS; Austin, CP; Diller, DJ; Inglese, J; Jadhav, A; Johnson, RL; Simeonov, A; Southall, NT | 1 |
Connor, SA; Hoeffer, CA; Klann, E; Nguyen, PV | 1 |
2 other study(ies) available for pd 98059 and 6-methyl-2-(phenylethynyl)pyridine
Article | Year |
---|---|
Characterization of chemical libraries for luciferase inhibitory activity.
Topics: Animals; Drug Evaluation, Preclinical; Enzyme Inhibitors; Fireflies; Luciferases; Models, Molecular; Structure-Activity Relationship | 2008 |
Fragile X mental retardation protein regulates heterosynaptic plasticity in the hippocampus.
Topics: Adrenergic beta-Agonists; Animals; Bicuculline; Biophysics; Dose-Response Relationship, Drug; Electric Stimulation; Emetine; Enzyme Inhibitors; Excitatory Amino Acid Antagonists; Excitatory Postsynaptic Potentials; Flavonoids; Fragile X Mental Retardation Protein; GABA-A Receptor Antagonists; Hippocampus; Immunosuppressive Agents; In Vitro Techniques; Isoproterenol; Long-Term Potentiation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Neuronal Plasticity; Neurons; Patch-Clamp Techniques; Pyridines; rap GTP-Binding Proteins; Sirolimus; Time Factors | 2011 |